Pendulum Stock

Pendulum develops microbiome interventions and drugs to improve healthcare by managing chronic illnesses and type 2 diabetes. Combining lab science and computational analysis, they offer a comprehensive view of each individual’s microbiome through targeted probiotics and prebiotics, helping clinicians identify specific markers and interventions for disease treatment.